Filing Flows › Health Care › DocGo (DCGO)
DocGo (DCGO) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 17, 2026 · DocGo (DCGO) Q2 2026 earnings results →
Q2 2026 Revenue down 9% year over year to $73.4M · 25¢ of every $1 of revenue lost · operating margin -24.4%
DocGo made $73.4M in Q2 2026 (-9% Y/Y): Transportation Services $52.0M, Mobile Health Services $21.4M. Operating margin -24.4%, net loss $18.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 17, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $73.4M in Q2 2026, down 9% year over year and down 3% from the previous quarter. Transportation Services was the largest line at 71% of revenue. Mobile Health Services lost $9.4M year over year (down 30%), 134% of the total change.
Operating costs exceeded revenue by $17.9M, an operating margin of -24.4%. Total costs fell 7% while revenue fell 9%. The fastest-growing cost line was Research & development (+17%). The quarter ended with a net loss of $18.0M, wider than the previous quarter's $16.7M loss. Minority interests bore $2.2M of it: to shareholders the quarter was a loss of $15.8M.
Operating cash flow was −$9.2M. Non-cash charges added back $2.7M of depreciation and amortization and $2.7M of share-based compensation. Working capital and other items added $3.4M. Capital expenditures of $321K exceeded it, leaving free cash flow of −$9.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 17, 2026 | $73.4M | -9% | -24.4% | −$18.0M | −$9.2M |
| Q1 2026 | 10-Q | May 11, 2026 | $75.6M | -21% | -24.8% | −$16.7M | −$4.7M |
| Q4 2025 | 10-K | Mar 16, 2026 | $74.9M | -38% | -139.6% | −$142M | −$10.5M |
| Q3 2025 | 10-Q | Nov 10, 2025 | $70.8M | -49% | -59.3% | −$29.7M | $1.7M |
| Q2 2025 | 10-Q | Aug 7, 2025 | $80.4M | -51% | -21.7% | −$13.3M | $34.0M |
| Q1 2025 | 10-Q | May 8, 2025 | $96.0M | -50% | -14.6% | −$11.1M | $9.2M |
| Q4 2024 | 10-K | Feb 27, 2025 | $121M | -39% | -6.2% | −$7.6M | $12.7M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Buys from
About DocGo
DocGo is leading the proactive healthcare revolution. We are democratizing access with our innovative care delivery platform that includes mobile health services, virtual care management and ambulance services. Our goal is to deliver healthcare at any address and help reshape the traditional healthcare system, driven by our mission to bring high quality, highly accessible care to all. DocGo’s proprietary technology platform, dedicated network of certified health professionals, including virtual care clinicians, and robust fleet of medical response vehicles provide services in all 50 states and the United Kingdom. DocGo’s vertically integrated approach helps elevate the quality of patient care and drive business efficiencies for municipalities, hospital networks and health insurance providers.
In its own words, from its 10-K, filed Mar 16, 2026.
DocGo against its Services-Health Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -9% against the peers' median +13%. Operating margin: -24.4% against the peers' median 5.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| DCGO DocGo | Q2 2026 | $73.4M | -9% | -24.4% |
| PRVA Privia Health Group | Q3 2026 | $657M | +13% | 3.1% |
| LFST LifeStance Health Group | Q3 2026 | $456M | +25% | 7.3% |
| PIII P3 Health Partners | Q2 2026 | $386M | +9% | 10.7% |
| PNTG Pennant Group | Q3 2026 | $302M | +32% | 5.5% |
| INNV InnovAge Holding | Q1 FY27 | $265M | +12% | 7.6% |
| USPH U S Physical Therapy | Q3 2026 | $223M | +13% | 11.3% |
| WGS GeneDx Holdings | Q2 2026 | $114M | +11% | -15.3% |
| OMDA Omada Health | Q3 2026 | $91.3M | +34% | 5.3% |
Source: DocGo 10-Q on SEC EDGAR · CIK 1822359 · Services-Health Services
13F: who owns DCGO and who is buying
More on DCGO
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results